Abbott Laboratories vs Sientra, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Abbott Laboratories is the larger company by market value: $181.1 B against $8 M for Sientra, Inc., 22639 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Sientra, Inc.). Sientra, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $71 M for Sientra, Inc.
- Abbott Laboratories made a net profit of $6.5 B, while Sientra, Inc. made a net loss of $90 M.
- Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -126.3% for Sientra, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Abbott Laboratories ABT · #117 in the world | Sientra, Inc. SIEN |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Medical Devices | Medical Devices |
| Founded | 1888 | 2003 |
| Size | ||
| Market cap | $181.1 B | $8 M* |
| Revenue | $44.3 B | $71 M |
| Net income | $6.5 B▲ best | $-90 M |
| Employees | 115,000 | — |
| Valuation | ||
| P/E ratio | 38.5× | — |
| Price to sales | 3.8× | — |
| Price to book | 3.5× | — |
| Free cash flow yield | 4.1% | — |
| Profitability | ||
| Gross margin | 56.4% | — |
| Operating margin | 18.2% | — |
| Net margin | 14.7% | — |
| Return on equity | 13.1% | — |
| Return on invested capital | 11.2% | — |
| Growth | ||
| Revenue growth | 5.7% | — |
| Revenue growth, 3 years a year | 0.5% | — |
| Earnings per share growth | -51.3% | — |
| Financial strength | ||
| Debt to equity | 0.3× | — |
| Cash | ||
| Free cash flow margin | 16.7% | — |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.8% | — |
| Strength scores | ||
| Piotroski F-score | 6 of 9 | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, Abbott Laboratories or Sientra, Inc.?
Abbott Laboratories is the larger company by market value: $181.1 B against $8 M for Sientra, Inc., 22639 times as much (market caps of Oct 30, 2026 for Abbott Laboratories and Jan 5, 2024 for Sientra, Inc.). Sientra, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, Abbott Laboratories or Sientra, Inc.?
Abbott Laboratories had more revenue: $44.3 B in the year to December 2025 against $71 M for Sientra, Inc. Abbott Laboratories made a net profit of $6.5 B, while Sientra, Inc. made a net loss of $90 M.
Which is more profitable, Abbott Laboratories or Sientra, Inc.?
Abbott Laboratories keeps more of each dollar of sales: a net margin of 14.7% against -126.3% for Sientra, Inc.